US Stock MarketDetailed Quotes

COGT Cogent Biosciences

Watchlist
  • 6.005
  • -0.005-0.08%
Trading Apr 26 15:03 ET
574.16MMarket Cap-2481P/E (TTM)

Cogent Biosciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
40.78%208.13M
33.11%58.23M
61.81%59.58M
31.32%47.09M
37.62%43.24M
95.68%147.84M
70.61%43.75M
85.79%36.82M
107.35%35.86M
145.45%31.42M
Selling and administrative expenses
31.14%34.38M
35.78%9.51M
37.30%9.45M
28.83%8.21M
21.03%7.2M
33.48%26.21M
36.62%7M
37.12%6.89M
30.02%6.38M
29.67%5.95M
-General and administrative expense
31.14%34.38M
35.78%9.51M
37.30%9.45M
28.83%8.21M
21.03%7.2M
33.48%26.21M
36.62%7M
37.12%6.89M
30.02%6.38M
29.67%5.95M
Research and development costs
42.86%173.76M
32.60%48.72M
67.45%50.13M
31.86%38.87M
41.49%36.04M
117.53%121.63M
79.11%36.74M
102.30%29.94M
137.96%29.48M
210.12%25.47M
Operating profit
-40.78%-208.13M
-33.11%-58.23M
-61.81%-59.58M
-31.32%-47.09M
-37.62%-43.24M
-95.68%-147.84M
-70.61%-43.75M
-85.79%-36.82M
-107.35%-35.86M
-145.45%-31.42M
Net non-operating interest income expense
227.83%13.08M
83.41%3.87M
179.87%4.2M
907.72%2.74M
2,019.63%2.27M
754.18%3.99M
1,871.96%2.11M
1,204.35%1.5M
126.67%272K
-14.40%107K
Non-operating interest income
227.83%13.08M
83.41%3.87M
179.87%4.2M
907.72%2.74M
2,019.63%2.27M
754.18%3.99M
1,871.96%2.11M
1,204.35%1.5M
126.67%272K
-14.40%107K
Other net income (expense)
-26.77%2.64M
-100.35%-7K
-59.15%268K
251.85%2.38M
28.39%3.61M
224.80%2.02M
-58.23%259K
5.30%656K
-28.51%677K
Other non- operating income (expenses)
-26.77%2.64M
-100.35%-7K
----
-59.15%268K
251.85%2.38M
28.39%3.61M
224.80%2.02M
-58.23%259K
5.30%656K
-28.51%677K
Income before tax
-37.20%-192.41M
-37.22%-54.37M
-57.95%-55.38M
-26.19%-44.08M
-25.96%-38.59M
-94.04%-140.24M
-59.03%-39.62M
-83.72%-35.06M
-111.05%-34.93M
-161.20%-30.63M
Income tax
Net income
-37.20%-192.41M
-37.22%-54.37M
-57.95%-55.38M
-26.19%-44.08M
-25.96%-38.59M
-94.04%-140.24M
-59.03%-39.62M
-83.72%-35.06M
-111.05%-34.93M
-161.20%-30.63M
Net income continuous Operations
-37.20%-192.41M
-37.22%-54.37M
-57.95%-55.38M
-26.19%-44.08M
-25.96%-38.59M
-94.04%-140.24M
-59.03%-39.62M
-83.72%-35.06M
-111.05%-34.93M
-161.20%-30.63M
Minority interest income
Net income attributable to the parent company
-37.20%-192.41M
-37.22%-54.37M
-57.95%-55.38M
-26.19%-44.08M
-25.96%-38.59M
-94.04%-140.24M
-59.03%-39.62M
-83.72%-35.06M
-111.05%-34.93M
-161.20%-30.63M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-37.20%-192.41M
-37.22%-54.37M
-57.95%-55.38M
-26.19%-44.08M
-25.96%-38.59M
-94.04%-140.24M
-59.03%-39.62M
-83.72%-35.06M
-111.05%-34.93M
-161.20%-30.63M
Basic earnings per share
-1.26%-2.42
-12.50%-0.63
-28.00%-0.64
16.90%-0.59
19.12%-0.55
-27.81%-2.39
1.53%-0.56
-4.17%-0.5
-65.12%-0.71
-100.00%-0.68
Diluted earnings per share
-1.26%-2.42
-12.50%-0.63
-28.00%-0.64
16.90%-0.59
19.12%-0.55
-27.81%-2.39
1.53%-0.56
-4.17%-0.5
-65.12%-0.71
-100.00%-0.68
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 40.78%208.13M33.11%58.23M61.81%59.58M31.32%47.09M37.62%43.24M95.68%147.84M70.61%43.75M85.79%36.82M107.35%35.86M145.45%31.42M
Selling and administrative expenses 31.14%34.38M35.78%9.51M37.30%9.45M28.83%8.21M21.03%7.2M33.48%26.21M36.62%7M37.12%6.89M30.02%6.38M29.67%5.95M
-General and administrative expense 31.14%34.38M35.78%9.51M37.30%9.45M28.83%8.21M21.03%7.2M33.48%26.21M36.62%7M37.12%6.89M30.02%6.38M29.67%5.95M
Research and development costs 42.86%173.76M32.60%48.72M67.45%50.13M31.86%38.87M41.49%36.04M117.53%121.63M79.11%36.74M102.30%29.94M137.96%29.48M210.12%25.47M
Operating profit -40.78%-208.13M-33.11%-58.23M-61.81%-59.58M-31.32%-47.09M-37.62%-43.24M-95.68%-147.84M-70.61%-43.75M-85.79%-36.82M-107.35%-35.86M-145.45%-31.42M
Net non-operating interest income expense 227.83%13.08M83.41%3.87M179.87%4.2M907.72%2.74M2,019.63%2.27M754.18%3.99M1,871.96%2.11M1,204.35%1.5M126.67%272K-14.40%107K
Non-operating interest income 227.83%13.08M83.41%3.87M179.87%4.2M907.72%2.74M2,019.63%2.27M754.18%3.99M1,871.96%2.11M1,204.35%1.5M126.67%272K-14.40%107K
Other net income (expense) -26.77%2.64M-100.35%-7K-59.15%268K251.85%2.38M28.39%3.61M224.80%2.02M-58.23%259K5.30%656K-28.51%677K
Other non- operating income (expenses) -26.77%2.64M-100.35%-7K-----59.15%268K251.85%2.38M28.39%3.61M224.80%2.02M-58.23%259K5.30%656K-28.51%677K
Income before tax -37.20%-192.41M-37.22%-54.37M-57.95%-55.38M-26.19%-44.08M-25.96%-38.59M-94.04%-140.24M-59.03%-39.62M-83.72%-35.06M-111.05%-34.93M-161.20%-30.63M
Income tax
Net income -37.20%-192.41M-37.22%-54.37M-57.95%-55.38M-26.19%-44.08M-25.96%-38.59M-94.04%-140.24M-59.03%-39.62M-83.72%-35.06M-111.05%-34.93M-161.20%-30.63M
Net income continuous Operations -37.20%-192.41M-37.22%-54.37M-57.95%-55.38M-26.19%-44.08M-25.96%-38.59M-94.04%-140.24M-59.03%-39.62M-83.72%-35.06M-111.05%-34.93M-161.20%-30.63M
Minority interest income
Net income attributable to the parent company -37.20%-192.41M-37.22%-54.37M-57.95%-55.38M-26.19%-44.08M-25.96%-38.59M-94.04%-140.24M-59.03%-39.62M-83.72%-35.06M-111.05%-34.93M-161.20%-30.63M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -37.20%-192.41M-37.22%-54.37M-57.95%-55.38M-26.19%-44.08M-25.96%-38.59M-94.04%-140.24M-59.03%-39.62M-83.72%-35.06M-111.05%-34.93M-161.20%-30.63M
Basic earnings per share -1.26%-2.42-12.50%-0.63-28.00%-0.6416.90%-0.5919.12%-0.55-27.81%-2.391.53%-0.56-4.17%-0.5-65.12%-0.71-100.00%-0.68
Diluted earnings per share -1.26%-2.42-12.50%-0.63-28.00%-0.6416.90%-0.5919.12%-0.55-27.81%-2.391.53%-0.56-4.17%-0.5-65.12%-0.71-100.00%-0.68
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg